Emphasizing the increased excitement seen in the Korean market, domestic exhibitors rose by 43% in 2019, with overseas exhibitors also rising by a remarkable 38%. Overall, CPhI Korea saw a 20% increase in attendees, with 6,111 executives attending from over 66 countries. In total, some 266 companies exhibited, 150 of which were international. The event was also used as a platform to announce several international partnerships, with international bodies exploring EDQM and CEP procedures through to GMP compliance and comparisons between national regulatory bodies.
In another significant move, a joint Memorandum of Understanding was signed between the Chilean Pharmaceutical Manufacturers Association (PROLMED) and the Korean Pharmaceutical Traders Association (KPTA). The Memorandum will see the exchange of information to facilitate increased import and export between the two countries, as well as collaboration on marketing and market analysis. This will include practical sessions between suppliers in each country via seminars, conferences, consultations, and association promotion. CPhI Korea is also seeing industry-academic partnerships coalesce, with a new partnership from Bio Healthcare i-CON designed to enhance SME’s technological capabilities.
“The interesting thing about the Korean market is that whilst exports have become increasingly attractive – which is helping pharma companies increase volumes – the event has also become of great interest to international companies planning to launch new products into the region. This is in addition to international ingredients suppliers helping to support the expanding finished dose industry. In fact, already looking ahead to next year, we have seen the majority of exhibitors re-booking and we have taken the decision early to expand the event and move to a larger exhibition hall,” commented Laura Murina, Brand Manager at Informa.
Beyond pharmaceuticals, functional ingredients and health products within Korea are also seeing tremendous growth rates, with this part of the event (Hi) expanding by 57% in the last year. An increasingly health-conscious consumer population is driving the growth in the market. Consequently, the event is seeing an influx of overseas ingredients and extracts coming to Korea to help underpin this burgeoning new product class.
Murina enthused: “The growth rates we have seen at this event are very much a mirror image of the excitement and potential that underpins this market and we would expect this to be one of the fastest-growing CPhI events globally. What we hope is that our event can help deliver on the undoubted potential here. It is a truly dynamic time for the industry from ingredients right through to biologicals and health products”.
The CPhI Korea conference also provided a window into the trends likely to affect the market over the next year, with a wide range of organisations providing insights on how to gain access to international markets – including case studies from the PMDA, Thai Food and Drug Administration, CCCMHPIE, and even the UN Industry Development Organisation. In fact, the CPhI Hosted Buyers Programme matched together buyers and exhibitors spanning some 4926 meetings and professionals from over 38 countries.
Commenting on how the event has become a hub for domestic-international partnerships, Evalar JSE – a manufacturer of medicinal products and dietary supplements – added “we were looking for innovative APIs and formulations and we made purchasing request onsite after one meeting. What was noticeable is that many of the exhibitors were looking to export overseas and it is very exciting to see how we can work together to develop these markets”.
CPhI Korea 2020 will take place in Hall C at the KOEX Centre in Seoul between the 26th and 28th August, and will be co-located alongside ICSE (contact service), P-MEC (pharmaceutical machinery & lab equipment), BioLIVE (biopharmaceuticals) and Hi (health ingredients), which along with the FDF zone, brings the entire supply chain together in one venue.
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; and Finished Dosage Formulation for every aspect of the finished dosage supply chain. CPhI provides an online buyer and supplier directory at CPhI-Online.com.
For more information visit https://www.cphi.com
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
The Informa Markets annual schedule of Pharmaceutical eventsnclude: CPhI Middle East & Africa (16-18 September, 2019 at the ADNEC – Abu Dhabi, United Arab Emirates); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (5-7, November, 2019 at the Messe in Frankfurt); CPhI & P-MEC India (26–28 November 2019 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); Pharmapack Europe (5-6 February, 2020 at the Paris Expo, Porte de Versailles – Paris, France); CPhI South East Asia (4-6 March, 2020 at the QSNCC – Bangkok, Thailand); CPhI Japan (16-18 March, 2020 at the Big Sight Exhibition Centre – Tokyo, Japan); CPhI North America (05 April - 07 May, 2020 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI and P-MEC China (22-24 June, 2020 at SNIEC – Shanghai, China); CPhI Korea (26-28 August 2020), COEX – Seoul, Korea).
 Part of the 2019 CPhI Annual Report to be released during CPhI Worldwide